Advancements in Biotechnology for Viral Infection Treatment Development
Koronis Pharmaceuticals worked on developing solutions for viral infections like HIV and hepatitis. The company focused on finding effective treatments that could remain functional even when viruses developed resistance. The primary goal was to develop long-term solutions for viral infections, ensuring that the treatments would continue to be effective as viruses evolve.
Utilizing Molecular Biology
Molecular biology played a crucial role in Koronis’s research. By studying viruses at the genetic level, scientists could better understand how viruses replicate and mutate. This information was used to develop targeted treatments that would be more effective and less likely to face resistance.
Cell-Based Testing
Koronis conducted testing using cell cultures. These lab-grown cells, infected with viruses, allowed researchers to see how the solutions performed in real-world conditions. By testing in cells, they could determine which approaches were most effective in halting viral replication.
Improving and Monitoring Solutions
Genomic Analysis
To improve treatments, Koronis relied on genomic analysis to track how viruses evolve over time. By analyzing viral genetic data, researchers could monitor how the virus changes and adjust the treatments to stay effective against new strains..
Biomolecular Sensors
Koronis employed biomolecular sensors to monitor viral loads and the effectiveness of treatments in real-time. These sensors tracked the presence of viruses, helping scientists make adjustments to improve the treatment process based on accurate, up-to-date data.